MeSH Browser

MeSH Heading: Lansoprazole
Tree Number(s): D02.886.640.074.249; D03.383.725.024.249; D03.633.100.103.034.249
Unique ID: D064747
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D064747
Scope Note: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Entry Term(s): 2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole; AG 1749; AG-1749; Agopton; Bamalite; Lansol; Lansoprazol; Lansoprazole Sodium; Lansoprazoles; Lanzor; Monolitum; Ogast; Ogastro; Opiren; Prevacid; Prezal; Pro Ulco; Promeco; Takepron; Ulpax; Zoton
Pharm Action: Anti-Ulcer Agents
Proton Pump Inhibitors
Registry Numbers: 0K5C5T2QPG; 0; GV9NY1U369
Related Numbers: GV9NY1U369
Public MeSH Note: 2014; LANSOPRAZOLE was indexed under 2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES 2007-2013 and under OMEPRAZOLE 1989-2006
History Note: 2014
Date Established: 2014/01/01
Date of Entry: 2013/07/08
Revision Date: 2017/01/17

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Concept UI: M0583189
Registry Numbers: 0K5C5T2QPG
Related Numbers: GV9NY1U369
Scope Note: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Terms: Lansoprazole Preferred Term
Term UI T840533
Date04/16/2013
LexicalTag NON
ThesaurusID; Lansoprazoles
Term UI T840515
Date04/15/2013
LexicalTag NON
ThesaurusID NLM (2014); 2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole
Term UI T840534
Date04/16/2013
LexicalTag NON
ThesaurusID NLM (2014); Lansoprazol
Term UI T840535
Date04/16/2013
LexicalTag NON
ThesaurusID NLM (2014)

Lansoprazole MeSH Descriptor Data 2024